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Concise statement: 
Wastewater-based epidemiology (WBE) could be used to evaluate public health interventions aimed 
at reducing substance use and potentially could contribute to prevalence estimates when modelled 
in combination with other data sources. However, it is unlikely to replace other methods just yet due 
to difficulties in obtaining and analysing sufficient samples and the limited evidence base around 
excretion factors.  
 
Commentary: 
Lai et al (1) add to a growing body of evidence suggesting that the routine monitoring of population-
level substance use through communal wastewater could be feasible. Their study of metabolites of 
alcohol and tobacco covers an impressive 45% of the Australian population and adds some support 
for the validity of wastewater-based measures by demonstrating broad consistency in geographical 
patterns over time and when compared with household survey data.  
As with the vast majority of wastewater studies to date, Lai et al (1) based inferences on just seven 
days of sampling per year (in this case, over a two-year period). Further study is needed of longer 
data series (2-4) to determine whether this sampling scheme is sufficient given the multiple sources 
of uncertainty and variability. For example, how representative one week of sampling typically is of a 
year will depend on the population size, the amount of consumption of the substance of interest and 
its excretion profile, in addition to any changes in consumption throughout the year (2). Until the 
total level of uncertainty relating to the sampling scheme is better understood, we should be 
cautious in interpreting apparent changes based on small numbers of samples.  
Although wastewater analysis has considerable potential for monitoring trends over time and 
making comparisons across locations, we are less optimistic about its use to estimate absolute 
consumption levels. This involves extrapolation of estimated metabolite loads based on the 
estimated proportion of the parent substance that is excreted as the metabolite. As noted by Lai et 
al (1), only an estimated 0.012% of all consumed alcohol is excreted as ethyl sulfate, the monitored 
metabolite.  This means that the inflation factor required to estimate the volume of alcohol actually 
consumed is large, leading to considerable uncertainty in consumption estimates and high sensitivity 
to small changes in this estimated proportion..  This is particularly worrying as there are very few 
studies on metabolite excretion.  For example, the figure of 0.012% for alcohol was based on a single 
study of 10 healthy, male volunteers (5).  We note, however, the remarkable agreement between 
the authors’ total estimate of the number of cigarettes smoked per capita in Australia and sales data 
(1), which helps to corroborate the excretion proportion. 
  
Lai et al (1) used a regression model, with population size and day of the week as predictors, to 
extrapolate consumption estimates in the population studied to the whole of Australia. This 
approach could be extended to include other predictors, such as area-level deprivation indicators or 
indeed sales figures if easily available. There are clear similarities to the ‘multiple indicator method’ 
that is often used to extrapolate capture-recapture-based prevalence estimates to other 
geographical areas (6,7). It will be feasible to generate credible intervals around the resulting 
estimates by extending the Monte Carlo simulation approach to a fully Bayesian analysis, performing 
the wastewater based calculations and the regression analyses simultaneously (8). By modelling 
multiple indicators of consumption in a single model we can reduce reliance on any one data source 
(9).  
The authors are right to highlight the utility of WBE for evaluating public health interventions that 
aim to reduce tobacco and alcohol (and potentially drug) consumption in the population. It is 
important, however, that statistical tests for change account for parameter uncertainty. WBE could 
be used to supplement and test the consistency of sales data and other routine health data – such 
as A&E attendances for alcohol and uptake of smoking-cessation clinics – and importantly to identify 
any geographical inequalities in consumption and in intervention effects. However, WBE data cannot 
tell us about changes in cessation or abstinence or in the pattern of use, for which population 
surveys are still required.  
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